.jpg?format=webp&width=780)
The article discusses the dependence of prostate cancer on the androgen receptor (AR) and the evolution of castration-resistant prostate cancer. Molecular studies have shown that most resistance mechanisms involve the reactivation of AR, making tumour cells resistant to castration. However, there is confusion about how to properly define preclinical models of prostate cancer, including cell lines. Understanding the limitations and advantages of preclinical models is crucial for the transfer of knowledge from scientific research to the clinic.
Like
Save
Share